Insights From Technical Analysis
1414 Degrees (ASX:14D) Breaks Out Again on Massive Volume. Will the prior pattern repeat?
1414 Degrees is an ASX-listed cleantech company developing silicon-based thermal storage, hydrogen and battery materials; investor interest reflects Aurora and SiNTL progress, fresh $2.69 million funding, and a high-volume share-price breakout that now needs follow-through.
Resolution Minerals (ASX: RML) Surges on Fresh Catalysts; Share Price Rebounds Strongly
Resolution Minerals (ASX: RML) has rebounded from $0.04 toward $0.07–$0.08, driven by U.S. critical minerals progress and rising investor interest. Despite volatility, strong project developments, infrastructure moves, and drilling activity are shifting sentiment and supporting renewed momentum.
Nanoveu (ASX: NVU) is at risk of breaching a critical support level. How much lower can its share price go?
Nanoveu (ASX: NVU) is a deep-tech Australian company pivoting toward ultra-low-power edge AI chips, but it remains under pressure from tiny revenue, ongoing losses, dilution, and competitive risks. Technically, the stock is testing support near 0.050, with 0.040 as the next key level if selling continues.
Anson Resources (ASX: ASN) Rebounds with Strong Upside as Investors React to Major Project Upgrade
Anson Resources rebounded near A$0.05 after a 650% resource upgrade at Green River, boosting investor sentiment. Still in development, it targets U.S. lithium supply, but remains high-risk, with weak technicals and key support at A$0.045.
Will Elixir Energy (ASX: EXR) break through a key resistance level, or is a near-term pullback ahead?
Elixir Energy (ASX: EXR) is advancing gas projects toward 2027 production, but its share price faces pressure from dilution, cash burn, and operational risks. Technically, the stock sits near key support, with momentum neutral and direction dependent on whether it holds support or breaks resistance.
How much lower can the breakdown in Appen (ASX: APX) take the share price?
Appen shares have broken down on weak fundamentals despite AI exposure, with downside risks toward ~A$1. While the business pivots to generative AI, declining core revenue and profitability issues keep it a fragile turnaround rather than a confirmed recovery story.